cloridrato de donepezila
biosintÉtica farmacÊutica ltda - outros produtos que atuam sobre o sistema nervoso
danpezil
glaxosmithkline brasil ltda - outros produtos que atuam sobre o sistema nervoso
hazol
ranbaxy farmacÊutica ltda - outros produtos que atuam sobre o sistema nervoso
senes
supera farma laboratÓrios s.a - outros produtos que atuam sobre o sistema nervoso
vitadiazin
nativita ind. com. ltda. - outros produtos com acao na pele e mucosas
cloridrato de donepezila
unichem farmacÊutica do brasil ltda - cloridrato de donepezila - outros produtos que atuam sobre o sistema nervoso
dupixent
sanofi medley farmacÊutica ltda. - dupilumabe - imunomodulador
vaxigrip tetra
sanofi medley farmacÊutica ltda. - cepa influenza tipo a (h1n1), cepa influenza tipo a (h3n2), cepa influenza tipo b, cepa influenza tipo b - vacinas; vacinas contra a gripe
rinvoq
abbvie deutschland gmbh & co. kg - upadacitinib - artrite, reumatóide - imunossupressores - rheumatoid arthritisrinvoq is indicated for the treatment of moderate to severe active rheumatoid arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs (dmards). rinvoq may be used as monotherapy or in combination with methotrexate. psoriatic arthritisrinvoq is indicated for the treatment of active psoriatic arthritis in adult patients who have responded inadequately to, or who are intolerant to one or more dmards. rinvoq may be used as monotherapy or in combination with methotrexate. axial spondyloarthritisnon-radiographic axial spondyloarthritis (nr-axspa)rinvoq is indicated for the treatment of active non-radiographic axial spondyloarthritis in adult patients with objective signs of inflammation as indicated by elevated c-reactive protein (crp) and/or magnetic resonance imaging (mri), who have responded inadequately to nonsteroidal anti-inflammatory drugs (nsaids). ankylosing spondylitis (as, radiographic axial spondyloarthritis)rinvoq is indicated for the treatment of active ankylosing spondylitis in adult patients who have responded inadequately to conventional therapy. atopic dermatitisrinvoq is indicated for the treatment of moderate to severe atopic dermatitis in adults and adolescents 12 years and older who are candidates for systemic therapy. ulcerative colitisrinvoq is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent. crohn’s diseaserinvoq is indicated for the treatment of adult patients with moderately to severely active crohn’s disease who have had an inadequate response, lost response or were intolerant to either conventional therapy or a biologic agent.
cloridrato de donepezila
nova quimica farmacÊutica s/a - cloridrato de donepezila - outros produtos que atuam sobre o sistema nervoso